COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 737
What It Measures
● Overall gut microbial diversity and stability
● Relative abundance of health-promoting vs pathogenic
bacteria
● Functional pathways (e.g., short-chain fatty acid production,
toxin metabolism, bile acid transformation)
● Dysbiosis patterns and loss of microbial balance
● Keystone species critical to gut ecosystem resilience
Key Keystone Species BiomeFx Reports On
● Akkermansia muciniphila 4 essential for maintaining mucous
layer integrity and gut barrier protection [2]
● Faecalibacterium prausnitzii 4 major butyrate producer;
anti-inflammatory function for colon health [2]
● Bifidobacterium species 4 early colonizers critical for
immune training and metabolic balance
What It Reveals
● Loss of keystone species associated with gut barrier
dysfunction, leaky gut, systemic inflammation, and chronic
disease risk
● Overrepresentation of pathogens (e.g., Proteobacteria,
Enterobacteriaceae)
● Depletion of short-chain fatty acid producers (leading to
colonocyte energy deficiency and mucosal damage)
● Early signs of dysbiosis-related disorders (e.g., IBS, IBD,
metabolic syndrome, cognitive decline)
BiomeFx Gut Testing offers clear, actionable targets for rebuilding
gut microbiota and optimizing immune resilience.
737
